Here's Why Chemours Tumbled 41.4% in May
The materials science company reported weak quarterly results, but environmental pollution risks are also piling up.
Chemours
CC
CC
$23.95
-$0.32
0.0%
BATS BZX Real Time Price as of June 14, 2019, 3:39 p.m.
View Interactive CC Charts
Chemours Company (The)
News & Analysis: Chemours
The Fool has written over 100 articles on Chemours.
Why PetMed Express, Chemours, and Affiliated Managers Group Slumped Today
Earnings, analysts, and other concerns hurt these stocks.
The Chemours Company (CC) Q1 2019 Earnings Call Transcript
CC earnings call for the period ending March 31, 2019.
Is Chemours Company a Buy?
The chemical company's shares were way down...then way up. Is there still room to outperform?
The Chemours Company (CC) Q4 2018 Earnings Conference Call Transcript
CC earnings call for the period ending December 31, 2018.
The Chemours Company (CC) Q4 2018 Earnings Conference Call Transcript
CC earnings call for the period ending December 31, 2018.
Here's Why Chemours Stock Gained 26.7% in January
Investors gave the chemicals firm a fresh look after a miserable performance in 2018.
Here's Why The Chemours Company Dropped 13.7% in November
The diversified specialty chemicals producer announced strong third-quarter 2018 earnings. What happened?
Here's Why Tronox Fell as Much as 35.5% Today and Sabotaged Its Peers
North American titanium dioxide producers are getting punished today, thanks to increased uncertainty heading into an important deadline.
Is Chemours a Buy?
With shares of the specialty chemicals manufacturer plunging more than 40% so far this year, the stock is certainly much cheaper.
